Ezetimibe And Simvastatin has 33 known drug interactions based on U.S. FDA drug labeling data. Of these, 21 are contraindicated combinations that should be avoided entirely. 10 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Amlodipine, Boceprevir, Clarithromycin. Patients taking Ezetimibe And Simvastatin should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 33
- Contraindicated
- 21
- Major
- 10
- Moderate
- 2
Contraindicated (21)
- Ezetimibe And Simvastatin + Amlodipine— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Boceprevir— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Clarithromycin— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Cobicistat— Strong CYP3A4 inhibitor that increases simvastatin plasma levels, elevating risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Cyclosporine— Contraindicated due to increased risk of myopathy and rhabdomyolysis with ezetimibe and simvastatin tablets.
- Ezetimibe And Simvastatin + Danazol— Contraindicated due to increased risk of myopathy and rhabdomyolysis with ezetimibe and simvastatin tablets.
- Ezetimibe And Simvastatin + Daptomycin— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Darunavir— Strong CYP3A4 inhibitor; concomitant use is contraindicated due to increased risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Erythromycin— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Gemfibrozil— Contraindicated due to increased risk of myopathy and rhabdomyolysis with ezetimibe and simvastatin tablets.
- Ezetimibe And Simvastatin + Itraconazole— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Ketoconazole— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Nefazodone— Strong CYP3A4 inhibitor that increases simvastatin plasma levels, elevating risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Nelfinavir— Strong CYP3A4 inhibitor; concomitant use is contraindicated due to increased risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Posaconazole— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Protease Inhibitors— Strong CYP3A4 inhibitors that increase simvastatin plasma levels, elevating risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Ritonavir— Strong CYP3A4 inhibitor; concomitant use is contraindicated due to increased risk of myopathy and rhabdomyolysis.
- Ezetimibe And Simvastatin + Simvastatin— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Telaprevir— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Telithromycin— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
- Ezetimibe And Simvastatin + Voriconazole— ] Ezetimibe and Simvastatin Tablets Drug Interactions Associated With Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , …
Major (10)
- Ezetimibe And Simvastatin + Amiodarone— Do not exceed 10 mg/20 mg ezetimibe and simvastatin tablets daily due to increased myopathy risk.
- Ezetimibe And Simvastatin + Diltiazem— Do not exceed 10 mg/10 mg ezetimibe and simvastatin tablets daily due to increased myopathy risk.
- Ezetimibe And Simvastatin + Dronedarone— Do not exceed 10 mg/10 mg ezetimibe and simvastatin tablets daily due to increased myopathy risk.
- Ezetimibe And Simvastatin + Fenofibrate— Combination increases exposure of ezetimibe; increased risk of cholelithiasis. If suspected, gallbladder studies indicat…
- Ezetimibe And Simvastatin + Grapefruit Juice— Avoid grapefruit juice due to increased simvastatin plasma levels and myopathy risk.
- Ezetimibe And Simvastatin + Lomitapide— For patients with HoFH, do not exceed 10 mg/20 mg ezetimibe and simvastatin tablets daily; special restrictions apply fo…
- Ezetimibe And Simvastatin + Niacin— Lipid-modifying doses (≥1 g/day) increase risk of adverse skeletal muscle effects; not recommended for Chinese patients.
- Ezetimibe And Simvastatin + Oral Anticoagulants— Simvastatin prolongs INR. Achieve stable INR before starting therapy and monitor frequently upon initiation or dose chan…
- Ezetimibe And Simvastatin + Ranolazine— Do not exceed 10 mg/20 mg ezetimibe and simvastatin tablets daily due to increased myopathy risk.
- Ezetimibe And Simvastatin + Verapamil— Do not exceed 10 mg/10 mg ezetimibe and simvastatin tablets daily due to increased myopathy risk.
Moderate (2)
- Ezetimibe And Simvastatin + Cholestyramine Light— Combination decreases exposure of ezetimibe, reducing efficacy.
- Ezetimibe And Simvastatin + Digoxin— Monitor digoxin levels during ezetimibe and simvastatin initiation.